Qu Cui

1.3k total citations
36 papers, 527 citations indexed

About

Qu Cui is a scholar working on Pathology and Forensic Medicine, Oncology and Neurology. According to data from OpenAlex, Qu Cui has authored 36 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pathology and Forensic Medicine, 12 papers in Oncology and 11 papers in Neurology. Recurrent topics in Qu Cui's work include Lymphoma Diagnosis and Treatment (12 papers), CNS Lymphoma Diagnosis and Treatment (10 papers) and CAR-T cell therapy research (6 papers). Qu Cui is often cited by papers focused on Lymphoma Diagnosis and Treatment (12 papers), CNS Lymphoma Diagnosis and Treatment (10 papers) and CAR-T cell therapy research (6 papers). Qu Cui collaborates with scholars based in China, Japan and Canada. Qu Cui's co-authors include Lehana Thabane, Marek Smieja, Fiona Smaill, Andrew McIvor, Yuanbo Liu, He Huang, Nan Ji, Yaming Wang, Yongxian Hu and Shiro Fujii and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Qu Cui

35 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qu Cui China 13 151 120 114 91 85 36 527
Sai Ravi Pingali United States 14 212 1.4× 95 0.8× 57 0.5× 51 0.6× 113 1.3× 63 529
Giammarco Surico Italy 11 191 1.3× 99 0.8× 72 0.6× 54 0.6× 34 0.4× 27 480
Roula Farah Lebanon 11 91 0.6× 116 1.0× 82 0.7× 45 0.5× 73 0.9× 39 683
Franklin Fuda United States 11 71 0.5× 75 0.6× 89 0.8× 40 0.4× 69 0.8× 51 395
Clifton C. Mo United States 11 177 1.2× 216 1.8× 51 0.4× 37 0.4× 73 0.9× 44 489
Ailin Zhao China 13 166 1.1× 107 0.9× 57 0.5× 28 0.3× 80 0.9× 47 519
Mary Taj United Kingdom 13 219 1.5× 77 0.6× 21 0.2× 76 0.8× 125 1.5× 29 550
Pimjai Niparuck Thailand 12 84 0.6× 77 0.6× 85 0.7× 67 0.7× 47 0.6× 56 405
Mohamad Zaidan France 16 114 0.8× 237 2.0× 103 0.9× 40 0.4× 78 0.9× 47 851
Anu Korula India 14 209 1.4× 202 1.7× 47 0.4× 12 0.1× 43 0.5× 112 724

Countries citing papers authored by Qu Cui

Since Specialization
Citations

This map shows the geographic impact of Qu Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qu Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qu Cui more than expected).

Fields of papers citing papers by Qu Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qu Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qu Cui. The network helps show where Qu Cui may publish in the future.

Co-authorship network of co-authors of Qu Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Qu Cui. A scholar is included among the top collaborators of Qu Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qu Cui. Qu Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Yuchen, et al.. (2023). Challenges in the management of primary central nervous system lymphoma. Critical Reviews in Oncology/Hematology. 188. 104042–104042. 3 indexed citations
2.
3.
Wu, Yuchen, et al.. (2021). Efficacy and Safety of Ibrutinib in Central Nervous System Lymphoma: A PRISMA-Compliant Single-Arm Meta-Analysis. Frontiers in Oncology. 11. 707285–707285. 15 indexed citations
4.
Wu, Yuchen, Xueyan Bai, Hong Zhu, et al.. (2021). Treatment of secondary central nervous system involvement in systemic aggressive B cell lymphoma using R-MIADD chemotherapy: a single-center study. Chinese Neurosurgical Journal. 7(1). 20–20. 3 indexed citations
5.
Hu, Yongxian, et al.. (2020). COVID-19 in Hematologic Malignancies: Big Challenges. SHILAP Revista de lepidopterología. 2(4). 173–173. 2 indexed citations
6.
7.
Wang, Yaming, Xueyan Bai, Qu Cui, et al.. (2019). STAT3 Activation Is Associated with Interleukin-10 Expression and Survival in Primary Central Nervous System Lymphoma. World Neurosurgery. 134. e1077–e1084. 5 indexed citations
8.
Wu, Yuchen, Yaming Wang, Xueyan Bai, et al.. (2019). Parenchymal central nervous system involvement in aggressive B-cell lymphoma: retrospective analysis of clinical and MRI features in a Chinese population. BMC Neurology. 19(1). 268–268. 4 indexed citations
9.
Hu, Yongxian, Jiasheng Wang, Chengfei Pu, et al.. (2018). Delayed Terminal Ileal Perforation in a Relapsed/Refractory B-Cell Lymphoma Patient with Rapid Remission Following Chimeric Antigen Receptor T-Cell Therapy. Cancer Research and Treatment. 50(4). 1462–1466. 10 indexed citations
10.
Wei, Guoqing, Yongxian Hu, Chengfei Pu, et al.. (2018). CD19 targeted CAR-T therapy versus chemotherapy in re-induction treatment of refractory/relapsed acute lymphoblastic leukemia: results of a case-controlled study. Annals of Hematology. 97(5). 781–789. 21 indexed citations
11.
Liu, Jing, Yaming Wang, Nan Ji, et al.. (2016). Promoter methylation attenuates SHP1 expression and function in patients with primary central nervous system lymphoma. Oncology Reports. 37(2). 887–894. 14 indexed citations
12.
Qian, Jun, Qu Cui, Yuanbo Liu, et al.. (2015). Isolated primary intracranial myeloid sarcoma with neuromeningeal infiltration: A case report. Oncology Letters. 9(4). 1647–1650. 8 indexed citations
13.
Despiégel, Nicolas, Neerav Monga, Qu Cui, et al.. (2015). Cost-Effectiveness of Dolutegravir in HIV-1 Treatment-Naive and Treatment-Experienced Patients in Canada. Infectious Diseases and Therapy. 4(3). 337–353. 18 indexed citations
14.
Hu, Yongxian, Qu Cui, Chao Luo, et al.. (2015). A promising sword of tomorrow: Human γδ T cell strategies reconcile allo-HSCT complications. Blood Reviews. 30(3). 179–188. 18 indexed citations
15.
Cui, Qu. (2011). Analysis of the composition and community structure of phytoplankton in Xingkai Lake. Freshwater Fisheries. 1 indexed citations
16.
Cui, Qu, Linda Robinson, Dawn Elston, et al.. (2011). Safety and Tolerability of Varenicline Tartrate (Champix ® /Chantix ® ) for Smoking Cessation in HIV-Infected Subjects: A Pilot Open-Label Study. AIDS Patient Care and STDs. 26(1). 12–19. 56 indexed citations
17.
Miki, Hirokazu, Shuji Ozaki, Shingen Nakamura, et al.. (2011). KRN5500, a spicamycin derivative, exerts anti‐myeloma effects through impairing both myeloma cells and osteoclasts. British Journal of Haematology. 155(3). 328–339. 4 indexed citations
18.
Hu, Yongxian, Qu Cui, Bin Liang, & He Huang. (2011). Relapsing Hematologic Malignancies after Haploidentical Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 17(8). 1099–1111. 4 indexed citations
19.
Cui, Qu, Hironobu Shibata, Asuka Oda, et al.. (2011). Targeting myeloma–osteoclast interaction with Vγ9Vδ2 T cells. International Journal of Hematology. 94(1). 63–70. 12 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sai Ravi Pingali Breakdown of academic impact, for papers by Giammarco Surico Breakdown of academic impact, for papers by Roula Farah Breakdown of academic impact, for papers by Franklin Fuda Breakdown of academic impact, for papers by Clifton C. Mo Breakdown of academic impact, for papers by Ailin Zhao Breakdown of academic impact, for papers by Mary Taj Breakdown of academic impact, for papers by Pimjai Niparuck Breakdown of academic impact, for papers by Mohamad Zaidan Breakdown of academic impact, for papers by Anu Korula
Rankless by CCL
2026